Truist Financial’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $491K | Buy |
24,023
+1,715
| +8% | +$35K | ﹤0.01% | 1958 |
|
|
2025
Q1 | $447K | Buy |
22,308
+1,005
| +5% | +$20.1K | ﹤0.01% | 1917 |
|
|
2024
Q4 | $568K | Buy |
21,303
+928
| +5% | +$24.7K | ﹤0.01% | 1787 |
|
|
2024
Q3 | $581K | Buy |
20,375
+6,158
| +43% | +$176K | ﹤0.01% | 1776 |
|
|
2024
Q2 | $310K | Buy |
14,217
+2,420
| +21% | +$52.7K | ﹤0.01% | 2269 |
|
|
2024
Q1 | $261K | Buy |
11,797
+167
| +1% | +$3.7K | ﹤0.01% | 2347 |
|
|
2023
Q4 | $251K | Sell |
11,630
-1,467
| -11% | -$31.7K | ﹤0.01% | 2399 |
|
|
2023
Q3 | $221K | Buy |
13,097
+198
| +2% | +$3.34K | ﹤0.01% | 2399 |
|
|
2023
Q2 | $177K | Buy |
+12,899
| New | +$177K | ﹤0.01% | 2446 |
|
|
2022
Q2 | – | Sell |
-6,510
| Closed | -$292K | – | 2641 |
|
|
2022
Q1 | $292K | Buy |
6,510
+379
| +6% | +$17K | ﹤0.01% | 2323 |
|
|
2021
Q4 | $262K | Sell |
6,131
-237
| -4% | -$10.1K | ﹤0.01% | 2411 |
|
|
2021
Q3 | $424K | Sell |
6,368
-171
| -3% | -$11.4K | ﹤0.01% | 2079 |
|
|
2021
Q2 | $480K | Buy |
+6,539
| New | +$480K | ﹤0.01% | 2064 |
|